|
|
Volumn 24, Issue 12, 2006, Pages 1491-1493
|
|
Anti-infective antibodies: Finding the path forward
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABTHRAX;
ALTASTAPH;
ANTHIM;
ANTIBIOTIC AGENT;
AUREXIS;
AUROGRAB;
BACTERIAL VACCINE;
BSYXA 110;
ETI 204;
HUMAN IMMUNOGLOBULIN;
MDX 066;
MDX 1303;
MDX 1388;
MONOCLONAL ANTIBODY;
MYCOGRAB;
PAGIBAXIMAB;
POLYCLONAL ANTIBODY;
RAXIBACUMAB;
SHIGAMAB;
STAPHVAX;
STAPHYLOCOCCUS VACCINE;
TEFIBAZUMAB;
VALORTIM;
VANCOMYCIN;
VERONATE;
ACTIVE IMMUNIZATION;
BACTERIAL INFECTION;
CLINICAL TRIAL;
DRUG MANUFACTURE;
DRUG PROGRAM;
DRUG RESEARCH;
HOSPITAL INFECTION;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNOLOGY;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
NONHUMAN;
PASSIVE IMMUNIZATION;
PRIORITY JOURNAL;
SHORT SURVEY;
STAPHYLOCOCCUS;
ANTI-BACTERIAL AGENTS;
ANTIBODY SPECIFICITY;
BACTERIAL INFECTIONS;
CLINICAL TRIALS;
DRUG DESIGN;
IMMUNIZATION, PASSIVE;
IMMUNOGLOBULINS;
METHICILLIN RESISTANCE;
STAPHYLOCOCCUS AUREUS;
VACCINATION;
|
|
EID: 33845700940
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1206-1491 Document Type: Short Survey |
|
Times cited : (24)
|
|
References (4)
|
